Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Fragmentation and inefficiencies in US equity markets: Evidence from the Dow 30.

Tivnan BF, Dewhurst DR, Van Oort CM, Ring JH 4th, Gray TJ, Tivnan BF, Koehler MTK, McMahon MT, Slater DM, Veneman JG, Danforth CM.

PLoS One. 2020 Jan 22;15(1):e0226968. doi: 10.1371/journal.pone.0226968. eCollection 2020.

2.

HER-2 gene amplification, HER-2 and epidermal growth factor receptor mRNA and protein expression, and lapatinib efficacy in women with metastatic breast cancer.

Press MF, Finn RS, Cameron D, Di Leo A, Geyer CE, Villalobos IE, Santiago A, Guzman R, Gasparyan A, Ma Y, Danenberg K, Martin AM, Williams L, Oliva C, Stein S, Gagnon R, Arbushites M, Koehler MT.

Clin Cancer Res. 2008 Dec 1;14(23):7861-70. doi: 10.1158/1078-0432.CCR-08-1056.

3.

Phase II and tumor pharmacodynamic study of gefitinib in patients with advanced breast cancer.

Baselga J, Albanell J, Ruiz A, Lluch A, Gascón P, Guillém V, González S, Sauleda S, Marimón I, Tabernero JM, Koehler MT, Rojo F.

J Clin Oncol. 2005 Aug 10;23(23):5323-33. Epub 2005 Jun 6.

PMID:
15939921
4.

Injured erythrocytes release adenosine deaminase into the circulation.

Jackson EK, Mi Z, Koehler MT, Carcillo JA Jr, Herzer WA.

J Pharmacol Exp Ther. 1996 Dec;279(3):1250-60.

PMID:
8968348
5.

FK506 (tacrolimus) in the treatment of steroid-resistant acute graft-versus-host disease in children undergoing bone marrow transplantation.

Koehler MT, Howrie D, Mirro J, Neudorf S, Blatt J, Corey S, Wollman M, Kelly-Ekeroth V, Reyes J.

Bone Marrow Transplant. 1995 Jun;15(6):895-9.

PMID:
7581088

Supplemental Content

Loading ...
Support Center